loading page

Drug Use Associated Tricuspid Valve Infective Endocarditis in Pregnancy
  • +7
  • Dishen Lin,
  • Clancy Mullan,
  • Uma Deshmukh,
  • Mert Bahtiyar,
  • Hillary Hosier,
  • Heather Lipkind,
  • Sonya Abdel-Razeq,
  • Saurabh Rajan,
  • Gilead Lancaster,
  • Colleen Pietras
Dishen Lin
Yale University School of Medicine
Author Profile
Clancy Mullan
Yale School of Medicine
Author Profile
Uma Deshmukh
Yale University School of Medicine
Author Profile
Mert Bahtiyar
Yale University School of Medicine
Author Profile
Hillary Hosier
Yale University School of Medicine
Author Profile
Heather Lipkind
Yale University School of Medicine
Author Profile
Sonya Abdel-Razeq
Yale University School of Medicine
Author Profile
Saurabh Rajan
Yale University School of Medicine
Author Profile
Gilead Lancaster
Yale University School of Medicine
Author Profile
Colleen Pietras
Yale University School of Medicine
Author Profile

Peer review status:ACCEPTED

20 May 2020Submitted to Journal of Cardiac Surgery
23 May 2020Assigned to Editor
23 May 2020Submission Checks Completed
23 May 2020Reviewer(s) Assigned
03 Jun 2020Review(s) Completed, Editorial Evaluation Pending
03 Jun 2020Editorial Decision: Accept

Abstract

We report a case of intravenous drug use-associated tricuspid valve endocarditis in a 28-year-old pregnant female at 26-weeks gestation. Despite appropriate intravenous antibiotics, the patient developed life-threatening complications and underwent planned cesarean delivery at 28 weeks 6 days gestation followed by interval tricuspid valve replacement one week later. Both the patient and her infant were successfully managed through the perioperative period.